Meta AnalysisID 7214
斑秃的治疗：安全性数据的系统文献综述
CRD42023486383
Are systemic corticosteroids (hydrocortisone, cortisone, prednisone, prednisolone, deflazacort, methylprednisolone, triamcinolone, betamethasone, dexamethasone and fludrocortisone), methotrexate, cyclosporine and azathio
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 7214
- Evidence Id
- 15772
- Core Evidence Id
- 15772
- Source Meta Analysis Id
- 7201
- Herb2 Meta Analysis Id
- HBMA007201
- Crd Id
- CRD42023486383
- Title
- Alopecia areata management: a systematic literature review on safety data.
- Review Question
- Are systemic corticosteroids (hydrocortisone, cortisone, prednisone, prednisolone, deflazacort, methylprednisolone, triamcinolone, betamethasone, dexamethasone and fludrocortisone), methotrexate, cyclosporine and azathioprine alone or in combination safe in the treatment of patients with AA?
- Study Type Included
- Clinical trials and observational studies.
- Condition Being Studied
- Alopecia areata (AA) is a condition that affects about 2% of the global population and imposes an important impact in quality of life. The basis of disease management is the use of corticosteroids; however, other options are available such as methotrexate, cyclosporine and azathioprine. The safety of a treatment strategy is an important issue for patients, physicians and policymakers.
- Participant
- Patients with the diagnosis of alopecia areata.
- Animal
- Human Disease Modelled
- Intervention
- Systemic corticosteroids (hydrocortisone, cortisone, prednisone, prednisolone, deflazacort, methylprednisolone, triamcinolone, betamethasone, dexamethasone and fludrocortisone), methotrexate, cyclosporine and azathioprine, used alone or in combination.
- Comparator Control
- No restriction.
- Main Outcome
- Safety profile of the preconized AA treatment strategies.
- Outcome Measure
- Additional Outcome
- Not applicable.
- Study Method
- Systematic review
- Keyword
- MeSH headings have not been applied to this record
- Contact
- Ana Carolina Padula [email protected]
- Organisational Affiliation
- Origin Health Co. https://www.originhealth.com.br/
- Funding Source
- Pfizer
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- Brazil
- Review Stage
- Review Ongoing
- First Submission Date
- 2023-11-28
- Registration Date
- 2023-12-09
- Anticipated Start Date
- 2023-07-03
- Anticipated Completion Date
- 2023-12-29
- Title Cn
- 斑秃的治疗：安全性数据的系统文献综述
- Title En
- Alopecia areata management: a systematic literature review on safety data.
- Bilingual Status
- complete